The MAPK3 Tpl2 controls innate and adaptive immunity by regulating TLR, TNF-α, and GPCR signaling in a variety of cell types. Its ablation gives rise to an anti-inflammatory phenotype characterized by resistance to LPS-induced endotoxin shock, DSS-induced colitis, and TNF-α-induced IBD. Here, we address the role of Tpl2 in autoimmunity. Our data show that the ablation and the pharmacological inhibition of Tpl2 protect mice from antiplatelet antibody-induced thrombocytopenia, a model of ITP. Thrombocytopenia in this model and in ITP is caused by phagocytosis of platelets opsonized with antiplatelet antibodies and depends on FcγR activation in splenic and hepatic myeloid cells. Further studies explained how Tpl2 inhibition protects from antibody-induced thrombocytopenia, by showing that Tpl2 is activated by FcγR signals in macrophages and that its activation by these signals is required for ERK activation, cytoplasmic Ca(2+) influx, the induction of cytokine and coreceptor gene expression, and phagocytosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774848 | PMC |
| http://dx.doi.org/10.1189/jlb.0113039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but serious prothrombotic adverse event following vaccination with adenovector-based COVID-19 vaccines. Laboratory findings indicate that anti-platelet factor 4 (PF4) immunoglobulin G antibodies are the causing factor for the onset of thromboembolic events in VITT. However, molecular mechanisms of cellular interactions, signaling pathways and involvement of different cell types in VITT antibody-mediated thrombosis are not fully understood.
View Article and Find Full Text PDFDesialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment.
Curr Issues Mol Biol
October 2024
Haematology Research Group, Central Clinical School, Faculty Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.
Immune thrombocytopenia (ITP) is an autoimmune disease in which platelet autoantibodies play a significant role in its pathogenesis. Regulatory T cell dysfunction and T cell-mediated cytotoxicity also contribute to thrombocytopenia. Current therapies are directed towards immune suppression and modulation as well as stimulation of platelet production with thrombopoietin receptor agonists.
View Article and Find Full Text PDFThe role of protein kinase C and the glycoprotein Ibα cytoplasmic tail in anti-glycoprotein Ibα antibody-induced platelet apoptosis and thrombocytopenia.
Thromb Res
December 2024
Jiangsu Institute of Hematology, Cyrus Tang Medical Institute, The First Affiliated Hospital Collaborative Innovation Center of Hematology, Soochow University, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, National Clinical Research Center for Hematological Diseases, Suzhou, China. Electronic address:
Article Synopsis
- Immune thrombocytopenia (ITP) is an autoimmune condition where patients have low platelet counts, especially those with anti-GPIbα autoantibodies that resist standard treatments.
- PKC activation is triggered by von Willebrand factor binding to GPIbα, leading to platelet activation, but its role in antibody-induced thrombocytopenia is unclear.
- The study reveals that PKC activation involves GPIbα clustering and PI3K activation, leading to platelet apoptosis, and suggests that targeting PKC could be a new treatment strategy for ITP.
Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP.
Blood Adv
April 2024
Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Fc gamma receptor (FcγR) IIIA is an important receptor for immunoglobulin G (IgG) and is involved in immune defense mechanisms as well as tissue destruction in some autoimmune diseases including immune thrombocytopenia (ITP). FcγRIIIA on macrophages can trigger phagocytosis of IgG-sensitized platelets, and prior pilot studies observed blockade of FcγRIIIA increased platelet counts in patients with ITP. Unfortunately, although blockade of FcγRIIIA in patients with ITP increased platelet counts, its engagement by the blocking antibody drove serious adverse inflammatory reactions.
View Article and Find Full Text PDFDiagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology.
J Thromb Haemost
March 2024
Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tübingen, University of Tübingen, Tübingen, Germany; Centre for Clinical Transfusion Medicine, Tübingen, Germany. Electronic address:
Article Synopsis
- - Heparin-induced thrombocytopenia (HIT) is an immune-related condition that leads to a decrease in platelet count and raises the risk of blood clots.
- - Diagnosing HIT requires both clinical evaluation and specific lab tests that identify the functional activities related to the disorder.
- - Experts emphasize the use of flow cytometry for diagnosing HIT and suggest that standardized protocols are essential for consistent and accurate results in clinical labs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!